balabanovj

Two Positive Notes for Arena Pharmaceuticals

For you, maybe qnexa would be the right choice, but for many others, safety would be the first consideration as well med/med interactions. Another potential use of Lorcaserin, provided the safety profile holds up long term is to prescribe it chronically for appetite mitigation. Most of us who lose weight fail to keep it off. As a doctor, and having treated many diabetics for example, who come in with skyrocketing blood sugar levels, you can tell them 'till you're blue in the face that they reeeeeeeeeeeeeeeeeeeealy need to lose weight, but 99/100 times, they just wont. Lorcaserin might be able to be Rx'd for years to acheive long term appetite suppression, enabling those who have lost weight, to keep it off.


On Sep 19 04:11 PM makk wrote:

> Hmm? My Dr says to me " I have this drug (vvus)you take once a day
> and you can lose 9% of your weight in 6 months to a year or you can
> take this drug (arna) 2x a day and lose 3%". Sounds like a no brainer
> to me. There is a reason the market values VVUS stock at double the
> cap of ARNA. I do think lorcasrin will be approved but the numbers
> dont compare to qnexa and contrave. Why buy 3rd in class?